310 related articles for article (PubMed ID: 23289503)
1. Induced expression of cytochrome P450 1A and NAD(P)H:quinone oxidoreductase determined at mRNA, protein, and enzyme activity levels in rats exposed to the carcinogenic azo dye 1-phenylazo-2-naphthol (Sudan I).
Stiborová M; Dračínská H; Martínek V; Svášková D; Hodek P; Milichovský J; Hejduková Ž; Brotánek J; Schmeiser HH; Frei E
Chem Res Toxicol; 2013 Feb; 26(2):290-9. PubMed ID: 23289503
[TBL] [Abstract][Full Text] [Related]
2. The environmental pollutant and carcinogen 3-nitrobenzanthrone induces cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase in rat lung and kidney, thereby enhancing its own genotoxicity.
Stiborová M; Dracínská H; Mizerovská J; Frei E; Schmeiser HH; Hudecek J; Hodek P; Phillips DH; Arlt VM
Toxicology; 2008 May; 247(1):11-22. PubMed ID: 18329153
[TBL] [Abstract][Full Text] [Related]
3. Induction of biotransformation enzymes by the carcinogenic air-pollutant 3-nitrobenzanthrone in liver, kidney and lung, after intra-tracheal instillation in rats.
Mizerovská J; Dračínská H; Frei E; Schmeiser HH; Arlt VM; Stiborová M
Mutat Res; 2011 Feb; 720(1-2):34-41. PubMed ID: 21167309
[TBL] [Abstract][Full Text] [Related]
4. 3-aminobenzanthrone, a human metabolite of the carcinogenic environmental pollutant 3-nitrobenzanthrone, induces biotransformation enzymes in rat kidney and lung.
Stiborová M; Dracínská H; Martínková M; Mizerovská J; Hudecek J; Hodek P; Liberda J; Frei E; Schmeiser HH; Phillips DH; Arlt VM
Mutat Res; 2009 May; 676(1-2):93-101. PubMed ID: 19398038
[TBL] [Abstract][Full Text] [Related]
5. Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes.
Stiborová M; Martínek V; Rýdlová H; Hodek P; Frei E
Cancer Res; 2002 Oct; 62(20):5678-84. PubMed ID: 12384524
[TBL] [Abstract][Full Text] [Related]
6. Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers.
Stiborová M; Martínek V; Rýdlová H; Koblas T; Hodek P
Cancer Lett; 2005 Apr; 220(2):145-54. PubMed ID: 15766589
[TBL] [Abstract][Full Text] [Related]
7. Modulation of CYP1A1-mediated oxidation of carcinogenic azo dye Sudan I and its binding to DNA by cytochrome b5.
Stiborová M; Martínek V; Schmeiser HH; Frei E
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():35-9. PubMed ID: 17159775
[TBL] [Abstract][Full Text] [Related]
8. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M
Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241
[TBL] [Abstract][Full Text] [Related]
9. The environmental pollutant and carcinogen 3-nitrobenzanthrone and its human metabolite 3-aminobenzanthrone are potent inducers of rat hepatic cytochromes P450 1A1 and -1A2 and NAD(P)H:quinone oxidoreductase.
Stiborová M; Dracínská H; Hájková J; Kaderábková P; Frei E; Schmeiser HH; Soucek P; Phillips DH; Arlt VM
Drug Metab Dispos; 2006 Aug; 34(8):1398-405. PubMed ID: 16714372
[TBL] [Abstract][Full Text] [Related]
10. Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice.
Arlt VM; Levová K; Bárta F; Shi Z; Evans JD; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Stiborová M
Chem Res Toxicol; 2011 Oct; 24(10):1710-9. PubMed ID: 21932800
[TBL] [Abstract][Full Text] [Related]
11. Benzo[
Dračínská H; Indra R; Jelínková S; Černá V; Arlt VM; Stiborová M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360828
[TBL] [Abstract][Full Text] [Related]
12. Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase.
Stiborová M; Frei E; Sopko B; Sopková K; Marková V; Lanková M; Kumstýrová T; Wiessler M; Schmeiser HH
Carcinogenesis; 2003 Oct; 24(10):1695-703. PubMed ID: 12869422
[TBL] [Abstract][Full Text] [Related]
13. Effect of sulfur dioxide inhalation on CYP1A1 and CYP1A2 in rat liver and lung.
Qin G; Meng Z
Toxicol Lett; 2005 Dec; 160(1):34-42. PubMed ID: 16023800
[TBL] [Abstract][Full Text] [Related]
14. The influence of dicoumarol on the bioactivation of the carcinogen aristolochic acid I in rats.
Stiborová M; Levová K; Bárta F; Šulc M; Frei E; Arlt VM; Schmeiser HH
Mutagenesis; 2014 May; 29(3):189-200. PubMed ID: 24598128
[TBL] [Abstract][Full Text] [Related]
15. The anticancer drug ellipticine is a potent inducer of rat cytochromes P450 1A1 and 1A2, thereby modulating its own metabolism.
Aimová D; Svobodová L; Kotrbová V; Mrázová B; Hodek P; Hudecek J; Václavíková R; Frei E; Stiborová M
Drug Metab Dispos; 2007 Oct; 35(10):1926-34. PubMed ID: 17656468
[TBL] [Abstract][Full Text] [Related]
16. NAD(P)H:quinone oxidoreductase expression in Cyp1a-knockout and CYP1A-humanized mouse lines and its effect on bioactivation of the carcinogen aristolochic acid I.
Levova K; Moserova M; Nebert DW; Phillips DH; Frei E; Schmeiser HH; Arlt VM; Stiborova M
Toxicol Appl Pharmacol; 2012 Dec; 265(3):360-7. PubMed ID: 22982977
[TBL] [Abstract][Full Text] [Related]
17. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2.
Stiborová M; Frei E; Wiessler M; Schmeiser HH
Chem Res Toxicol; 2001 Aug; 14(8):1128-37. PubMed ID: 11511187
[TBL] [Abstract][Full Text] [Related]
18. Enzymes oxidizing the azo dye 1-phenylazo-2-naphthol (Sudan I) and their contribution to its genotoxicity and carcinogenicity.
Stiborova M; Schmeiser HH; Frei E; Hodek P; Martinek V
Curr Drug Metab; 2014; 15(8):829-40. PubMed ID: 25658126
[TBL] [Abstract][Full Text] [Related]
19. Maternal intake of quercetin during gestation alters ex vivo benzo[a]pyrene metabolism and DNA adduct formation in adult offspring.
Vanhees K; van Schooten FJ; Moonen EJ; Maas LM; van Waalwijk van Doorn-Khosrovani SB; Godschalk RW
Mutagenesis; 2012 Jul; 27(4):445-51. PubMed ID: 22334599
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the induction of a 4S beta-naphthoflavone-binding protein, cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase in beta-naphthoflavone-treated rats.
Brauze D
Toxicol Lett; 2004 Sep; 152(2):111-6. PubMed ID: 15302092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]